Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

389 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate.
Kato M, Hirakawa A, Sato H, Hanazawa R, Naito Y, Tochigi K, Sano T, Ishida S, Funahashi Y, Fujita T, Matsukawa Y, Hattori R, Tsuzuki T. Kato M, et al. Among authors: hirakawa a. Int J Clin Oncol. 2021 Apr;26(4):764-769. doi: 10.1007/s10147-020-01841-4. Epub 2021 Jan 1. Int J Clin Oncol. 2021. PMID: 33385274
Prognostic factors in patients with uterine carcinosarcoma: a multi-institutional retrospective study from the Japanese Gynecologic Oncology Group.
Harano K, Hirakawa A, Yunokawa M, Nakamura T, Satoh T, Nishikawa T, Aoki D, Ito K, Ito K, Nakanishi T, Susumu N, Takehara K, Watanabe Y, Watari H, Saito T. Harano K, et al. Among authors: hirakawa a. Int J Clin Oncol. 2016 Feb;21(1):168-76. doi: 10.1007/s10147-015-0859-7. Epub 2015 Jun 18. Int J Clin Oncol. 2016. PMID: 26084780
The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation.
Kato M, Tsuzuki T, Kimura K, Hirakawa A, Kinoshita F, Sassa N, Ishida R, Fukatsu A, Kimura T, Funahashi Y, Matsukawa Y, Hattori R, Gotoh M. Kato M, et al. Among authors: hirakawa a. Mod Pathol. 2016 Feb;29(2):166-73. doi: 10.1038/modpathol.2015.146. Epub 2016 Jan 8. Mod Pathol. 2016. PMID: 26743470 Free article.
Authors' Reply.
Hirakawa A, Sato H. Hirakawa A, et al. Stat Med. 2016 Feb 10;35(3):479-80. doi: 10.1002/sim.6751. Stat Med. 2016. PMID: 26757958 No abstract available.
Design of a single-arm clinical trial of regenerative therapy by periurethral injection of adipose-derived regenerative cells for male stress urinary incontinence in Japan: the ADRESU study protocol.
Shimizu S, Yamamoto T, Nakayama S, Hirakawa A, Kuwatsuka Y, Funahashi Y, Matsukawa Y, Takanari K, Toriyama K, Kamei Y, Narimoto K, Yamanishi T, Ishizuka O, Mizuno M, Gotoh M. Shimizu S, et al. Among authors: hirakawa a. BMC Urol. 2017 Sep 25;17(1):89. doi: 10.1186/s12894-017-0282-7. BMC Urol. 2017. PMID: 28946874 Free PMC article. Clinical Trial.
389 results